1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Patología Molecular del Cáncer

Patología Molecular del Cáncer

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Araujo-Castro M, Casals G, Goi J, Lamas C, García Cano AM, Rebollo-Román Á, Morales M, Sebastian-Valles F, Marazuela M, Hernández-Alfonso J, Ruz-Caracuel I, Hanzu FA.

    Impact of the Cosecretion of Cortisol on Surgical Outcomes and in the Urinary Steroid Profile in Primary Aldosteronism.

    Endocrine Practice . : .

    [doi:10.1016/j.eprac.2026.05.023]

  • Barretina-Ginesta MP, Madariaga A, Barahona Orpinell M, Gallego A, Guerra Alía EM, Matias-Guiu X, Sanchez Heras AB, Casla-Barrio S, Castaño F, Gonzalez Concepción M, Navarro López M, Hierro Racionero C, Ruz Torres M, Gaba García L.

    Multidisciplinary management of advanced ovarian cancer in Spain: expert recommendations for achieving maximum survival and improving patient care.

    Clinical & Translational Oncology . : .

    [doi:10.1007/s12094-026-04467-6]

  • Mendes F, Vieira RJ, Alípio M, Esposito G, Panzuto F, Dell'Unto E, Rodriguez-Santiago E, Hernandez AV, Caracuel IR, Neves JC, Ferreira A, Moll F, Pioche M, Soares EG, Amaro P, Souto M, Xavier S, Cotter J, Ponte S, Silva JA, Magalhães RK, Gomes LC, Laranjo A, Gomes R, Soares C, Cardoso R, Gupta S, Bourke M, Gonçalves N, Ortigão R, Libânio D, Rimondi A, Murino A, Despott EJ, Tribonias G, Zormpas P, Wartski A, Jacques J, Cecinato P, Barbara G, Sassatelli R, Sereni G, Schaffitzel KM, Goelder S, Calabrese G, Sferrazza S, Craciun A, Moura M, Tornai T, Tate D, Mavrogenis G, Walter B, Uchima H, Allgaier HP, Berr F, Frias J, Marques M, Gullo I, Carneiro F, O'Toole D, Santos-Antunes J, Pinto BS, Macedo G, Morais R.

    Outcomes of Gastroduodenal Neuroendocrine Tumors After Endoscopic Resection in the Western Setting - A Target Trial Emulation.

    Clinical Gastroenterology and Hepatology . : .

    [doi:10.1016/j.cgh.2026.09.021]

  • Fernández IP, Lorenzo VB, Dominguez RG, Gómez CI, Molina-Cerrillo J, Carbonero IG, Feliciangeli E, Ruiz SG, de Liaño AG, Valderrama BP, Sánchez ÁR, Morcuende RS, Rodríguez CS, Quintela MEL, Díaz EG, Padró JGI, Puente J, Guzman JCV, Sanchez JG, Kareaga MM, Zambrana MDCB, de Velasco G, Cabrero IR, García-Donas J, Munarriz J, Sarrió RG, Núñez NF, Gordoa TA, Esteban E.

    Prognostic value of PD-L1 in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic first line drugs (PROANG-SOGUG study).

    Clinical & Translational Oncology . : .

    [doi:10.1007/s12094-026-04543-x]

  • Velasco-Ruiz A, Núñez-Torres R, Pita G, Torres-Ruiz R, Díaz-Talavera A, Tejera-Perez H, Wildiers H, Lambrechts D, Hatse S, Delombaerde D, Van Brussel T, Alonso MR, Álvarez N, Herráez B, Alonso-Gordoa T, Talavera-Calle P, Serrano-Antolín JM, Campos-Olivas R, Robledo M, Vulsteke C, Rodríguez-Perales S, Zamora P, López-Fernández T, Gonzalez-Neira A.

    Identification of STYXL1 as novel susceptibility gene for anthracycline-induced cardiotoxicity in breast cancer patients.

    CARDIOVASCULAR RESEARCH . : .

    [doi:10.1093/cvr/cvag236]

  • Pérez-García JM, Llombart-Cussac A, López-Miranda E, Cortes A, Garcia I, Galve-Calvo E, Ruiz-Borrego M, Cochs A, Perelló-Martorell A, Morales S, Boronat Ruiz L, Marín-Liébana S, Saavedra C, Blancas I, Hinojo C, López Flores M, Ladoire S, Schmid P, Freyer G, Rui Zhang R, Alcalá-López D, Carvalho-Santos J, Boix O, Barrios CH, Curigliano G, Bartsch R, Hardy Bessard AC, Wasserman T, Cortés J.

    Study design of the phase III ADELA trial of elacestrant with or without everolimus in ESR1-mutated ER+/HER2- advanced breast cancer after progression on endocrine therapy plus a CDK4/6 inhibitor.

    Future Oncology . : 1-13.

    [doi:10.1080/14796694.2026.2753794]

  • Incorvaia L, Mollica V, Fiala O, Fujita K, Ürün Y, Melichar B, Molina-Cerrillo J, Alonso-Gordoa T, Basso U, Bourlon MT, Seront E, Giorgi U, Fita MJJ, Rescigno P, Taha T, Maluf FC, Poprach A, Summa S, Buchler T, Galli L, Kopecky J, Aurilio G, Kucharz J, Messina C, Polho GB, Scagliarini S, Grillone F, Bastos DA, Formisano L, Spinelli GP, Mosca A, Rizzo A, Bamias A, Monteiro FSM, Soares A, Massari F, Armstrong AJ, Santoni M.

    Real-World HRR Testing Pathways and Patterns of Detected Alterations in Prostate Cancer From the Multinational ARON-3 Study.

    PROSTATE . : .

    [doi:10.1002/pros.70269]

  • Pérez-García JM, Cortés J, Ruiz-Borrego M, Stradella A, Bermejo B, Escrivá-de-Romaní S, Reboredo C, Albacar C, Martínez-Jáñez N, Iranzo V, Ribelles N, Dalenc F, Prat A, Schmid P, Gebhart G, Marmé F, Di Cosimo S, Braga S, Colleoni M, Antonarelli G, Notini G, Gion M, García-Mosquera JJ, Sanz L, Martinez-Garcia E, Meya A, Dustin D, Amaya-Garrido A, Guerrero-Martínez JA, Alcalá-López D, Rodríguez-Morató J, Mina L, Mancino M, Llombart-Cussac A.

    5-year outcomes of chemotherapy de-escalation in HER2-positive early breast cancer and exploratory circulating tumor DNA analyses from the randomized phase 2 PHERGain trial.

    NATURE MEDICINE . : .

    [doi:10.1038/s41591-026-04723-w]